Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile

International Journal of Cancer

Volumn 132, Issue 4, 2012, Pages 916-923

  Ferreccio, Catterina ^a   Barriga, María Isabel ^a   Lagos, Marcela ^a   Ibáñez, Carolina ^a   Poggi, Helena ^a   González, Francisca ^a   Terrazas, Solana ^a   Katki, Hormuzd A ^b   Núñez, Felipe ^a   Cartagena, Jaime ^a   Van De Wyngard, Vanessa ^a   Viñales, Daysi ^c   Brañes, Jorge ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Servicio de Salud Metropolitano sur Oriente   (Chile)

Author keywords

cancer prevention; cervical cancer screening; HPV DNA testing; Papanicolaou; screening trial

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CHILE; CLINICAL PRACTICE; COLPOSCOPY; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DNA SCREENING; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILE; COLPOSCOPY; DEVELOPING COUNTRIES; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84871373397     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27662     Document Type: Article

References (38)

1. Chile Ministry of Health, Departamento de Estadísticas e Información de Salud. Mortalidad. http://www.deis.cl/estadisticas- mortalidad/ (in Spanish; accessed Dec 12, 2011).
2. Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22: 2675-86.
3. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011; 378: 1461-84.
4. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26S: K29-K41.
5. Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000; 92: 818-25. (Pubitemid 30368038)
6. Ferreccio C, Bratti MC, Sherman ME, et al. A comparison of single and combined visual, cytological, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 815-23. (Pubitemid 37151514)
7. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
8. Moy LM, Zhao FH, Li LY, et al. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral. Int J Cancer 2010; 127: 646-56.
9. Sepulveda C, Prado R,. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience. Cancer Detect Prev 2005; 29: 405-411. (Pubitemid 41406134)
10. Suarez E, Prieto M,. Cervical cancer: the Chilean perspective. Int J Gynaecol Obstet 2006; 95: S235-38.
11. Meijer CJLM, Berkhof J, Castle PE, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older. Int J Cancer 2009; 124: 516-20.
12. Schatzkin A, Connor RJ, Taylor PR, et al. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees: example of automated cytometry for early detection of cervical cancer. Am J Epidemiol 1987; 125: 672-8. (Pubitemid 17047140)
13. Katki HA, Li Y, Edelstein DW, et al. Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens. Stat Med 2011; 31: 436-48.
14. Arbyn M, Ronco G, Cuzick J, et al. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer 2009; 125: 2489-96.
15. Gravitt PE, Paul P, Katki HA, et al. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a Peri-Urban Community in Andhra Pradesh, India. PLoS ONE 2010; 5: e13711.
16. Chile Ministry of Health, Departamento de Estadísticas e Información de Salud. Cobertura. http://www.deis.cl/cobertura/ (in Spanish; accessed March 26, 2012).
17. Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk hpv, routine cytology or colposcopy. Int J Cancer 2000; 89: 529-34.
18. Almonte M, Ferreccio C, Winkler JL, et al. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 2007; 121: 796-802. (Pubitemid 47106209)
19. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357: 1579-88. (Pubitemid 47598400)
20. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008; 123: 153-160. (Pubitemid 351705203)
21. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871-76. (Pubitemid 37518501)
22. Instituto Nacional de Estadisticas de Chile. Censo de Poblacion y Vivienda 1992, 2002. http://www.ine.cl/canales/usuarios/censos-digitalizados.php (in Spanish; accessed December 12, 2011).
23. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103: 1-16.
24. The World Bank. World Development Indicators & Global Development Finance database, Chile, GDP per capita constant 2000 US$, 1990-2010. http://databank.worldbank.org (in Spanish; accessed December 12, 2011).
25. Instituto Nacional de Estadísticas de Chile. Evolucion de la Mortalidad en Chile segun causas de muerte y edad, 1990-2007. http://www.ine.cl/canales/menu/publicaciones/calendario-de-publicaciones/pdf/ 010211/evo90-07-010211.pdf (in Spanish; accessed March 26, 2012).
26. Murillo R, Almonte M, Pereira A, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008; 26S: L37-48.
27. OECD. Society at a Glance 2011: OECD Social Indicators. OECD Publishing 2011; page 67.
28. The World Bank. Indicator: GINI index. http://data.worldbank.org/ indicator/SI.POV.GINI (accessed December 12, 2011).
29. Chile Ministry of Social Development. Encuesta CASEN 1990, 2009 database.
30. OECD. Health at a Glance 2011: OECD Indicators. OECD Publishing 2011; page 119.
31. Chile Ministry of Health, Departamento de Estadísticas e Información de Salud. Natalidad. http://www.deis.cl/estadisticas- natalidad/ (in Spanish; accessed March 26, 2012).
32. Lynge E, Rebolj M,. Primary HPV screening for cervical cancer prevention: results from European trials. Nat Rev Clin Oncol 2009; 6: 699-706.
33. Ronco G, van Ballegooijen M, Becker N, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009; 45: 2659-70.
34. Castle PE, Stoler MH, Wright TC, et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011; 12: 880-90.
35. González E, Molina T, Montero A, et al. Sexual behavior and gender differences among adolescents consulting at a university public health system. Rev Méd Chile 2007; 135: 1261-9.
36. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095-1101. (Pubitemid 44116919)
37. Sarian LO, Derchain SF, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. J Med Screen 2005; 12: 142-9. (Pubitemid 41337147)
38. Wright T, Kuhn L,. Alternative approaches to cervical cancer screening for developing countries. Best Pract Res Cl Ob 2012; 26: 197-208.